An Interventional Study Using Individualized Homoeopathic Medicines With Miasmatic Approach in Management of Post-Menopausal Syndrome. A Single Arm Open Label study.
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- To identify the underlying prevalent miasm.
研究概览
简要总结
This is a single arm, open label, interventional study which aims to assess the utility of individualized homoeopathic medicine with miasmatic approach in management of post-menopausal syndrome. Individualized homoeopathic medicine will be prescribed in centesimal scale after detailed case taking. Menopause rating scale will be calculated every month up to 6 months. The difference between the menopause rating scale before and after the treatment will be compared and analyzed. Hormone replacement treatment gained a lot of popularity and was previously advised for menopause symptoms. Nonetheless, research from the Women’s Health Initiative revealed a higher risk of Alzheimer’s and cardiovascular disease. When menopause approaches, an estimated 80% of women have physical or psychological symptoms that alter their quality of life. Homoeopathic management can be cost effective compared to conventional method.
Therefore, the present study is undertaken to explore how individualized homoeopathic medicines selected on the basis of miasmatic approach can prove to be useful in the management of Post menopausal syndrome.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 40.00 Year(s) 至 70.00 Year(s)（—）
- 性别
- Female
入选标准
- •Female patient who have attained menopause i.e. amenorrhea for last 12 consecutive months.
- •Female patient presenting with symptoms of Post-menopausal syndrome i.e. mood swings, hot flushes, insufficient sleep, and genitourinary problems/sexual dysfunction etc.
- •Diagnostic criteria are mainly on clinical presentation.
- •Females willing to participate in study and ready to provide informed written consent.
排除标准
- •Female patients who have undergone artificial menopause or surgical menopause and premature menopause.
- •Females suffering from any other systemic disorders such as diabetes mellitus, cardiac disorder, thyroid dysfunction and established case of mental illness etc.
- •Women having anti-depressents, HRT etc.
- •or any other medication that may influence the outcome of study.
- •Patients with post-menopausal bleeding, malignancy and uterine fibroid.
- •Females not willing to participate in study.
- •Patients participating in any other ongoing study.
结局指标
主要结局
To identify the underlying prevalent miasm.
时间窗: 24 weeks
次要结局
- To compare the menopause rating scale at baseline and after 3 months to assess the utility of individualized homoeopathic medicine.(4 weeks, 12 weeks)
研究者
Dr Kanupriya
State National Homoeopathic Medical College And Hospital, 1-Viraj Khand, Gomti Nagar, Lucknow (UP)